References
- Zhang C , DuQ, ChenLet al. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease. Eur. J. Med. Chem.116, 200–209 (2016).
- Zhang P , XuS, ZhuZ, XuJ. Multi-target design strategies for the improved treatment of Alzheimer's disease. Eur. J. Med. Chem.176, 228–247 (2019).
- Schelterns P , FeldmanH. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol.2(9), 539–547 (2003).
- Digiacomo M , ChenZ, WangSet al. Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD. Bioorg. Med. Chem. Lett.25(4), 807–810 (2015).
- Singh M , SilakariO. Design, synthesis and biological evaluation of novel 2-phenyl-1-benzopyran-4-one derivatives as potential poly-functional anti-Alzheimer's agents. RSC Adv.6(110), 108411–108422 (2016).
- Cai P , FangS, YangHet al. Donepezil-butylated hydroxytoluene (BHT) hybrids as anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties. Eur. J. Med. Chem.157, 161–176 (2018).
- Xie S , WangX, LiJ, YangL, KongL. Design, synthesis and evaluation of novel tacrine–coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease. Eur. J. Med. Chem.64, 540–553 (2013).
- Wang C , WuZ, CaiHet al. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site AChsterase inhibitors. Bioorg. Med. Chem. Lett.25(22), 5212–5216 (2015).
- Lan J , ZhangT, LiuYet al. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site AChsterase inhibitors. Eur. J. Med. Chem.133, 184–196 (2017).
- Baharloo F , MosleminMH, NadriHet al. Benzofuran-derived benzylpyridinium bromides as potent AChsterase inhibitors. Eur. J. Med. Chem.93, 196–201 (2015).
- Akrami H , MirjaliliBF, KhoobiMet al. Indolinone-based AChsterase inhibitors: synthesis, biological activity and molecular modeling. Eur. J. Med. Chem.84, 375–381 (2014).
- Alipour M , KhoobiM, ForoumadiAet al. Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site AChsterase inhibitors. Bioorg. Med. Chem.20(24), 7214–7222 (2012).
- Wang J , WangC, WuZet al. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site AChsterase inhibitors (Part II). Chem. Biol. Drug. Des.91(3), 756–762 (2018).
- Wu J , LingJ, WangXet al. Discovery of a potential anti-ischemic stroke agent: 3-pentylbenzo[c]thiophen-1(3H)-one. J. Med. Chem.55(16), 7173–7181 (2012).
- Luo Z , ShengJ, SunYet al. Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen. J. Med. Chem.56(22), 9089–9099 (2013).
- Sakai T , MiyataK, UtakaM, TakedaA. Me3SiCl‐NaI‐CH3CN as an efficient and practical reducing agent for benzylic alcohols. Tetrahedron Lett.28(33), 3817–3818 (1987).
- Bari SS , BhallaA, NagpalY, MehtaSK, BhasinKK. Synthesis and characterization of novel trans-3-benzyl/(diphenyl)methyl/naphthyl seleno substituted monocyclic β-lactams: x-ray structure of trans-1-(4’-methoxyphenyl)-3-(diphenyl)methylseleno-4-(4’-methoxyphenyl)azetidin-2-one. J. Organomet. Chem.695(17), 1979–1985 (2010).
- Ellman GL , CourtneyKD, AndresVJr, FeatherstoneRM. A new and rapid colorimetric determination of AChsterase activity. Biochem. Pharmacol.7(2), 88 (1961).
- Rizzo S , RivièReC, PiazziLet al. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, β amyloid aggregation, and Aβ neurotoxicity. J. Med. Chem.51(10), 2883–2886 (2008).
- Cheng F , LiW, ZhouYet al. ADMETSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. Chem. Inf. Model.52, 3099–3015 (2012).